LivaNova PLC · Electromedical & Electrotherapeutic Apparatus

LIVN

Low riskNext report: In 7 days (est.)

View price ↗

The short version

A company still losing money with growing sales.

Going well

Sales up 11% in the latest quarter vs a year ago
Sales up 11% last year

Watch out for

Losing money

Money moves

No insider buying or selling in the last 30 days
Institutions added 0.9% to their holdings in the quarter ending June 2026 (168 bought, 121 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$80.56-0.4% that day

Company value: $4.4B; Share price times all shares
Price vs profit (P/E): 23.8x; You pay about $24 for each $1 of yearly profit
Price vs sales: 3.0x; Company value is 3.0 times a year of sales
Cash vs value: 12%; Cash as a share of company value
Debt vs value: 8%; Debt as a share of company value

From LIVN's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$390.6M+11% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $1.5B, up 12% from the 12 months before. Over 5 years, sales grew about 8.2% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of LIVN. Starting points are the company's recent numbers.

Sales growth+12% a yearRecently: +12% a yearProfit margin13%Last 12 months: 12.8%P/E at the end24xToday: 23.8x. Many steady companies trade at 12x to 25xShare count change+1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$2.6B

Profit in 5 years$337M

Price these guesses point to$139.73+73% vs $80.56 todayAbout +12% a year, before dividends

What today's price needs: with a 13% margin and a 24x P/E, sales would have to grow about 0.3% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/7Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-19.2%
PassDebt under half of equityNot relying on borrowed money.0.31x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-17.5%
MissProfitable every yearSteady profits, not one good year.2 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$173.3M
MissShare count not growingNot diluting owners. Falling means buybacks.+2.0% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.67.7%

Revenue: $1.4B; +10.7% vs prior year
5-year growth: +8.2%/yr; revenue, per year
Total debt: $376.1M; 0.31x equity
Current ratio: 1.36x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.